Global pharma major Lupin Limited (Lupin) today announced that its Unit-2 manufacturing facility located in Mandideep, India, has successfully completed a GMP inspection by the United States Food and Drug Administration (U.S. FDA). The inspection was conducted from August 7 to August 11, 2023 and concluded
Mankind Pharma, a leading pharmaceutical company in India, is thrilled to announce the association of superstar Kartik Aaryan as the brand ambassador for Manforce Condoms. As the country's number one brand with a remarkable 30% market share, Mankind and Aaryan share a common vision of
Acquisition of biologics manufacturing facility in Bangalore to complete by the end of the third quarter in FY 24 US FDA approval for API manufacturing plant in Mangalore received Acquisition of land in Hyderabad to support long term growth in research services Syngene International Limited
National: After the phenomenal success of the first edition, a revised edition of the book ‘The Perfect Pill: 10 Steps to Build a Strong Healthcare Brand’ by Gauri Chaudhari was launched worldwide recently. The book elaborates on brand-building concepts and suggests necessary steps before applying
Tata Consultancy Services to Help GE HealthCare Advance the Transformation of its Global Information Technology Operating Model to Accelerate Innovation and Improve Resilience Tata Consultancy Services (TCS) (BSE: 532540, NSE: TCS) has expanded its long-standing relationship with GE HealthCare Technologies Inc. (GE HealthCare), a leading
Alkem Laboratories, a renowned pharmaceutical company, announced its entry into the field of Ophthalmology with the launch of an extensive portfolio of affordable and quality eye care products. This strategic expansion demonstrates Alkem's commitment to innovation and its dedication to meeting the diverse needs of
Sanofi Healthcare India Pvt. Ltd. today announced that it has received marketing authorization for Dupixent® (dupilumab), the first biologic medicine for the treatment of moderate-to-severe atopic dermatitis in adults whose disease is not adequately controlled with topical prescription therapies or when those therapies are not
The company has consolidated its position in GCC, ASEAN, Balkan and Caribbean regions with marketing approvals from Oman, Malaysia, Bosnia and Trinidad & Tobago for important chemotherapy drugs With this, the number of marketing approvals for its oncology products across 75 countries has gone
Patients and clinicians are united in a vision for the future; low trust in AI, interoperability, burnout, and care accessibility top the list of challenges Double-blinded quantitative survey of 5,500 patients and patient advocates along with 2,000 clinicians across eight countries, as well as
The company expects this approval for Meropenem 500mg, Meropenem 1000mg, Meropenem 2000mg, Oxaliplatin 5mg/ml, Paclitaxil 6mg/ml, Cisplatin 1mg/ml, Imipenem/Cilastatin 500mg/500mg of its Carbapenem & Oncology production facilities in Baddi to pave the way for GMP certifications from European Medicines Agency and other Pharmaceutical Inspection
